Vycor Medical (VYCO) Capital Expenditures (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 160,400.00% |
| Dec 31, 2022 | -235.42% |
| Dec 31, 2021 | -104.89% |
| Sep 30, 2021 | -22.38% |
| Jun 30, 2021 | -65.29% |
| Mar 31, 2021 | 1,146.61% |
| Dec 31, 2020 | -81.07% |
| Sep 30, 2020 | 200.92% |
| Jun 30, 2020 | -92.77% |
| Mar 31, 2020 | 48.74% |
| Dec 31, 2019 | 97.06% |
| Sep 30, 2019 | 2,470.49% |
| Jun 30, 2019 | -110.61% |
| Mar 31, 2019 | -8.59% |
| Dec 31, 2018 | 5.33% |
| Sep 30, 2018 | -82.15% |
| Jun 30, 2018 | 178.19% |
| Mar 31, 2018 | -42.31% |
| Dec 31, 2017 | -68.28% |
| Sep 30, 2017 | 333.50% |
| Jun 30, 2017 | -76.61% |
| Mar 31, 2017 | 144.39% |
| Dec 31, 2016 | 263.34% |
| Sep 30, 2016 | 162.60% |
| Jun 30, 2016 | -82.19% |
| Mar 31, 2016 | -89.46% |
| Dec 31, 2015 | 691.09% |
| Sep 30, 2015 | 47.24% |
| Jun 30, 2015 | 11.94% |
| Sep 30, 2014 | 41.03% |
| Jun 30, 2014 | 9.22% |
| Mar 31, 2014 | -24.48% |
| Dec 31, 2013 | -42.88% |
| Sep 30, 2013 | 583.35% |
| Jun 30, 2013 | -0.10% |
| Mar 31, 2013 | 26.39% |
| Dec 31, 2012 | 208.60% |
| Sep 30, 2012 | -73.09% |
| Jun 30, 2012 | 19.15% |
| Mar 31, 2012 | 141.24% |
| Dec 31, 2011 | -386.90% |
| Sep 30, 2011 | -54.24% |
| Jun 30, 2011 | 1,130.38% |
| Mar 31, 2011 | -93.83% |